- Home
- ATNM vs WGRX Comparison
ATNM vs WGRX Comparison
Compare ATNM & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- WGRX
- Stock Information
- Founded
- ATNM 2000
- WGRX 2022
- Country
- ATNM United States
- WGRX United States
- Employees
- ATNM N/A
- WGRX N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- WGRX Other Pharmaceuticals
- Sector
- ATNM Health Care
- WGRX Health Care
- Exchange
- ATNM Nasdaq
- WGRX Nasdaq
- Market Cap
- ATNM 50.2M
- WGRX 43.9M
- IPO Year
- ATNM N/A
- WGRX 2025
- Fundamental
- Price
- ATNM $1.29
- WGRX $0.58
- Analyst Decision
- ATNM Strong Buy
- WGRX
- Analyst Count
- ATNM 2
- WGRX 0
- Target Price
- ATNM $4.50
- WGRX N/A
- AVG Volume (30 Days)
- ATNM 306.1K
- WGRX 42.0M
- Earning Date
- ATNM 11-14-2025
- WGRX 11-19-2025
- Dividend Yield
- ATNM N/A
- WGRX N/A
- EPS Growth
- ATNM N/A
- WGRX N/A
- EPS
- ATNM N/A
- WGRX N/A
- Revenue
- ATNM N/A
- WGRX $36,738,599.00
- Revenue This Year
- ATNM N/A
- WGRX N/A
- Revenue Next Year
- ATNM N/A
- WGRX N/A
- P/E Ratio
- ATNM N/A
- WGRX N/A
- Revenue Growth
- ATNM N/A
- WGRX 82384.51
- 52 Week Low
- ATNM $1.03
- WGRX $0.34
- 52 Week High
- ATNM $2.41
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- ATNM 40.17
- WGRX 44.94
- Support Level
- ATNM $1.23
- WGRX $0.61
- Resistance Level
- ATNM $1.40
- WGRX $0.70
- Average True Range (ATR)
- ATNM 0.09
- WGRX 0.13
- MACD
- ATNM -0.01
- WGRX 0.02
- Stochastic Oscillator
- ATNM 19.61
- WGRX 22.87
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.